logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8183238 B1

PDFFull Text
Expired
Date of Patent:
May. 22, 2012

Filed:

Jun. 16, 2010

Bicyclic and tricyclic compounds as kat ii inhibitors

Applicants:

Michelle M. Claffey, Stonington, CT (US);

Amy B. Dounay, Ledyard, CT (US);

Matthew M. Hayward, Old Lyme, CT (US);

Suobao Rong, Groton, CT (US);

Patrick R. Verhoest, Old Lyme, CT (US);

Jamison B. Tuttle, Westbrook, CT (US);

Xinmin Gan, Groton, CT (US);

Inventors:

Michelle M. Claffey, Stonington, CT (US);

Amy B. Dounay, Ledyard, CT (US);

Matthew M. Hayward, Old Lyme, CT (US);

Suobao Rong, Groton, CT (US);

Patrick R. Verhoest, Old Lyme, CT (US);

Jamison B. Tuttle, Westbrook, CT (US);

Xinmin Gan, Groton, CT (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:

Feng Shao

Primary Examiner:

Sun Jae Loewe

Int. Cl.
CPC ...
A61K 31/52 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/4375 (2006.01); A61K 31/473 (2006.01); A61K 31/4741 (2006.01); A61K 31/506 (2006.01); A61K 31/501 (2006.01); A61K 31/517 (2006.01); C07D 473/30 (2006.01); C07D 473/20 (2006.01); C07D 413/12 (2006.01); C07D 405/10 (2006.01); C07D 401/10 (2006.01); C07D 401/04 (2006.01); C07D 471/04 (2006.01); C07D 215/58 (2006.01); C07D 221/10 (2006.01); C07D 413/10 (2006.01); C07D 491/048 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds of Formula X: wherein A, X, Y, Z, R, R, and Rare as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other neurodegenerative and/or neurological disorders in mammals, including humans.

Find Patent Forward Citations

Claffey, Michelle. (2012). Bicyclic and tricyclic compounds as kat ii inhibitors (U.S. Patent No. 8183238). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8183238

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…